$88.06
2.22%
Downside
Day's Volatility :3.79%
Upside
1.61%
49.73%
Downside
52 Weeks Volatility :52.35%
Upside
5.21%
Period | Lemaitre Vascular Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 13.66% | 5.1% | 0.0% |
6 Months | 28.29% | 4.9% | 0.0% |
1 Year | 54.57% | 16.6% | 0.0% |
3 Years | 47.85% | 13.2% | -22.3% |
Market Capitalization | 2.0B |
Book Value | $14.22 |
Dividend Share | 0.6 |
Dividend Yield | 0.73% |
Earnings Per Share (EPS) | 1.67 |
PE Ratio | 52.73 |
PEG Ratio | 2.09 |
Wall Street Target Price | 95.75 |
Profit Margin | 18.33% |
Operating Margin TTM | 25.75% |
Return On Assets TTM | 8.27% |
Return On Equity TTM | 12.49% |
Revenue TTM | 205.6M |
Revenue Per Share TTM | 9.2 |
Quarterly Revenue Growth YOY | 11.4% |
Gross Profit TTM | 104.9M |
EBITDA | 55.2M |
Diluted Eps TTM | 1.67 |
Quarterly Earnings Growth YOY | 0.44 |
EPS Estimate Current Year | 1.85 |
EPS Estimate Next Year | 2.05 |
EPS Estimate Current Quarter | 0.47 |
EPS Estimate Next Quarter | 0.42 |
What analysts predicted
Upside of 8.73%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 105.6M | ↑ 4.66% |
Net Income | 22.9M | ↑ 33.57% |
Net Profit Margin | 21.73% | ↑ 4.7% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 117.2M | ↑ 11.05% |
Net Income | 17.9M | ↓ 21.83% |
Net Profit Margin | 15.3% | ↓ 6.43% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 129.4M | ↑ 10.35% |
Net Income | 21.2M | ↑ 18.32% |
Net Profit Margin | 16.4% | ↑ 1.1% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 154.4M | ↑ 19.37% |
Net Income | 26.9M | ↑ 26.8% |
Net Profit Margin | 17.42% | ↑ 1.02% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 161.7M | ↑ 4.68% |
Net Income | 20.6M | ↓ 23.31% |
Net Profit Margin | 12.77% | ↓ 4.65% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 193.5M | ↑ 19.69% |
Net Income | 30.1M | ↑ 45.89% |
Net Profit Margin | 15.56% | ↑ 2.79% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 47.1M | ↑ 14.95% |
Net Income | 6.0M | ↑ 7.34% |
Net Profit Margin | 12.83% | ↓ 0.91% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 50.1M | ↑ 6.46% |
Net Income | 8.1M | ↑ 34.07% |
Net Profit Margin | 16.16% | ↑ 3.33% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 47.4M | ↓ 5.4% |
Net Income | 7.5M | ↓ 7.36% |
Net Profit Margin | 15.82% | ↓ 0.34% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 48.9M | ↑ 3.1% |
Net Income | 8.5M | ↑ 12.84% |
Net Profit Margin | 17.32% | ↑ 1.5% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 53.5M | ↑ 9.4% |
Net Income | 9.9M | ↑ 16.8% |
Net Profit Margin | 18.49% | ↑ 1.17% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 55.8M | ↑ 4.43% |
Net Income | 11.8M | ↑ 19.61% |
Net Profit Margin | 21.17% | ↑ 2.68% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 153.1M | ↑ 21.19% |
Total Liabilities | 22.9M | ↑ 38.06% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 188.3M | ↑ 23.03% |
Total Liabilities | 40.2M | ↑ 75.89% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 252.8M | ↑ 34.23% |
Total Liabilities | 80.2M | ↑ 99.62% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 292.8M | ↑ 15.82% |
Total Liabilities | 38.7M | ↓ 51.83% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 310.5M | ↑ 6.04% |
Total Liabilities | 42.3M | ↑ 9.38% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 346.8M | ↑ 11.69% |
Total Liabilities | 48.9M | ↑ 15.62% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 314.9M | ↑ 1.41% |
Total Liabilities | 40.7M | ↓ 3.72% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 326.5M | ↑ 3.68% |
Total Liabilities | 42.6M | ↑ 4.76% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 334.0M | ↑ 2.31% |
Total Liabilities | 45.4M | ↑ 6.41% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 346.8M | ↑ 3.82% |
Total Liabilities | 48.9M | ↑ 7.72% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 354.0M | ↑ 2.07% |
Total Liabilities | 45.5M | ↓ 7.01% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 363.1M | ↑ 2.58% |
Total Liabilities | 43.5M | ↓ 4.2% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 19.5M | ↓ 14.7% |
Investing Cash Flow | -7.1M | ↓ 75.64% |
Financing Cash Flow | -4.4M | ↓ 5620.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 14.2M | ↓ 27.31% |
Investing Cash Flow | -24.1M | ↑ 241.6% |
Financing Cash Flow | -4.6M | ↑ 4.66% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 34.8M | ↑ 145.43% |
Investing Cash Flow | -52.9M | ↑ 119.46% |
Financing Cash Flow | 32.2M | ↓ 795.69% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 35.1M | ↑ 0.87% |
Investing Cash Flow | -61.1M | ↑ 15.48% |
Financing Cash Flow | 13.7M | ↓ 57.39% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 25.4M | ↓ 27.7% |
Investing Cash Flow | -10.4M | ↓ 83.02% |
Financing Cash Flow | -9.2M | ↓ 167.39% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.3M | ↓ 44.1% |
Investing Cash Flow | -3.0M | ↑ 637.31% |
Financing Cash Flow | -1.8M | ↓ 14.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 11.9M | ↑ 422.29% |
Investing Cash Flow | -9.6M | ↑ 225.2% |
Financing Cash Flow | 502.0K | ↓ 127.51% |
Sell
Neutral
Buy
Lemaitre Vascular Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Lemaitre Vascular Inc | 9.66% | 28.29% | 54.57% | 47.85% | 172.21% |
![]() Intuitive Surgical, Inc. | 5.02% | 20.15% | 58.74% | 31.28% | 184.98% |
![]() Resmed Inc. | 16.09% | 27.14% | 62.7% | -17.28% | 81.24% |
![]() Becton, Dickinson And Company | 0.02% | -2.08% | -12.88% | -9.76% | -9.75% |
![]() West Pharmaceutical Services Inc | 1.18% | -17.93% | -26.4% | -35.64% | 104.36% |
![]() Alcon Ag | 3.83% | 8.9% | 15.02% | 11.44% | 61.54% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Lemaitre Vascular Inc | 52.73 | 52.73 | 2.09 | 1.85 | 0.12 | 0.08 | 0.01 | 14.22 |
![]() Intuitive Surgical, Inc. | 81.91 | 81.91 | 4.06 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
![]() Resmed Inc. | 35.33 | 35.33 | 2.05 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
![]() Becton, Dickinson And Company | 46.72 | 46.72 | 1.08 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
![]() West Pharmaceutical Services Inc | 42.71 | 42.71 | 5.15 | 6.51 | 0.2 | 0.11 | 0.0 | 35.49 |
![]() Alcon Ag | 42.64 | 42.64 | 3.53 | 3.05 | 0.05 | 0.03 | 0.0 | 42.35 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Lemaitre Vascular Inc | Buy | $2.0B | 172.21% | 52.73 | 18.33% |
![]() Intuitive Surgical, Inc. | Buy | $169.4B | 184.98% | 81.91 | 27.65% |
![]() Resmed Inc. | Buy | $36.0B | 81.24% | 35.33 | 21.79% |
![]() Becton, Dickinson And Company | Buy | $67.4B | -9.75% | 46.72 | 7.13% |
![]() West Pharmaceutical Services Inc | Buy | $21.8B | 104.36% | 42.71 | 18.25% |
![]() Alcon Ag | Buy | $46.7B | 61.54% | 42.64 | 11.44% |
Insights on Lemaitre Vascular Inc
Revenue is up for the last 4 quarters, 47.41M → 55.84M (in $), with an average increase of 5.3% per quarter
Netprofit is up for the last 4 quarters, 7.50M → 11.82M (in $), with an average increase of 14.1% per quarter
In the last 1 year, Resmed Inc. has given 62.7% return, outperforming this stock by 8.1%
BlackRock Inc
Conestoga Capital Advisors, LLC
Vanguard Group Inc
Copeland Capital Management, LLC
Geneva Capital Management
Ranger Investment Management LP
lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.
Organization | Lemaitre Vascular Inc |
Employees | 614 |
CEO | Mr. George W. LeMaitre |
Industry | Health Technology |
A Spac I Acquisition Corp
$88.06
-0.03%
Keyarch Acquisition Corp
$88.06
-0.03%
Connexa Sports Technologies Inc
$88.06
-0.03%
Us Value Etf
$88.06
-0.03%
First Wave Biopharma Inc
$88.06
-0.03%
Global X Msci Next Emerging
$88.06
-0.03%
Fat Projects Acquisition Corp
$88.06
-0.03%
Capital Link Global Fintech
$88.06
-0.03%
Applied Uv Inc
$88.06
-0.03%